The Role of Constitutive Activation of FMS-related Tyrosine Kinase-3 and NRas/KRas Mutational Status in Infants With KMT2A-rearranged Acute Lymphoblastic Leukemia

Haematologica - Italy
doi 10.3324/haematol.2017.169870
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Current Hematologic Malignancy Reports
Cancer ResearchOncologyHematology
2011English

Tyrosine Kinase Inhibitors in BCR-ABL Positive Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

FLT3 (FMS-like Tyrosine Kinase 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

FMS-related Tyrosine Kinase 3 Ligand (Flt3L)/Cd135 Axis in Rheumatoid Arthritis

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2013English

Tyrosine Kinase Fusion Genes in Pediatric BCR-ABL1-like Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2016English

The Outcome of Allogeneic Hematopoietic Cell Transplantation for Children With FMS-Like Tyrosine Kinase 3 Internal Tandem Duplication–Positive Acute Myelogenous Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Constitutive Phosphoinositide 3-Kinase Activation in Acute Myeloid Leukemia Is Not Due to P110δ Mutations

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Rationale for Targeting BCL6 in MLL-rearranged Acute Lymphoblastic Leukemia

Genes and Development
GeneticsDevelopmental Biology
2019English

Upfront Treatment With the First and Second-Generation Tyrosine Kinase Inhibitors in Ph-Positive Acute Lymphoblastic Leukemia

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy